Drugmakers urged to give poorer nations access to more antibiotics

The article quotes Jayasree K. Iyer, CEO of the Access to Medicine Foundation, stating there is "little incentive for drugmakers to sell their antibiotics and antifungals in poorer countries, where they face thin profit margins and fragile supply chains."

The author addresses the report –  titled "Access is a major driver of antibiotic resistance. How can pharma take action?" – noting: “Infections that are resistant to drugs can spread rapidly without people’s access to essential antibiotics and antifungals that treat serious systemic infections such as cryptococcal meningitis, a type of meningitis caused by a fungus."

"The people who face the highest risk of infection and the highest rates of drug resistance have the hardest time getting the antibiotics they need to survive severe bacterial and fungal infections."